These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 6573309)

  • 1. Cefotetan: a new cephamycin.
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():1-239. PubMed ID: 6573309
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefotetan and beta-lactamases. I. An analysis of the affinity of cefotetan for beta-lactamases.
    Labia R; Morand A; Verchere-Beaur C; Doré JC
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():147-52. PubMed ID: 6601654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in-vitro activity of cefotetan (ICI 156834), a new cephamycin derivative, with that of cefoxitin.
    Chattopadhyay B; Teli JC
    J Antimicrob Chemother; 1982 Aug; 10(2):151-4. PubMed ID: 6956565
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro susceptibility of Salmonella strains to cefotetan and other cephalosporins.
    Zamboni C; Fava C; Fera MT; Focà A
    Boll Ist Sieroter Milan; 1984 Mar; 63(1):37-41. PubMed ID: 6591925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An embryotoxicity study in Macaca fascicularis with cefotetan disodium (a cephamycin antibiotic).
    Allen DG; Clark R; Palmer AK; Heywood R
    Toxicol Lett; 1982 Apr; 11(1-2):43-7. PubMed ID: 6953621
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of cefotetan in the treatment of lower respiratory tract infections.
    Nolen TM; Phillips HL; Hall HJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():233-6. PubMed ID: 6573322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal pharmacokinetics and toxicology of cefotetan--a new cephamycin antibiotic.
    Suzuki H; Imamura K; Yoshida T; Shibata M; Matsuzawa T; Ozaki H; Sakai T; Shiobara Y; Tachibana A; Yano K
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():179-83. PubMed ID: 6573314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of new broad-spectrum cephamycin, cefotetan administered intravenously on human fecal flora (author's transl)].
    Nakaya R; Chida T; Shibaoka H; Sagara H
    Jpn J Antibiot; 1982 Mar; 35(3):856-63. PubMed ID: 6954292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotetan elimination in patients with varying degrees of renal dysfunction.
    Wright N; Wise R; Hegarty T
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():213-6. PubMed ID: 6573319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tolerance of single intramuscular doses of cefotetan in normal Caucasian volunteers.
    Yates RA; Cockshott ID; Houghton HL; Wardleworth A; Adam H; Donnelly RJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():207-12. PubMed ID: 6573318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of storage temperature and time on stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injection.
    Smith BR
    Am J Hosp Pharm; 1983 Jun; 40(6):1024-5. PubMed ID: 6307045
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers.
    Yates RA; Adam HK; Donnelly RJ; Houghton HL; Charlesworth EA; Laws EA
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():185-91. PubMed ID: 6573315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of indicators for cephamycin bioassay.
    Rani S; Sarada I; Sircar A; Sridhar P
    Indian J Exp Biol; 1996 Aug; 34(8):816-7. PubMed ID: 8979493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and tolerance of a 24-h infusion of cefotetan disodium (with and without loading dose) in normal Caucasian volunteers.
    Adam HK; Houghton HL; Yates RA; Young J; Donnelly RJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():193-9. PubMed ID: 6573316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and cost implications of the new cephalosporins. Vancouver, British Columbia, Canada, August 21-22, 1987. Proceedings.
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):687-746. PubMed ID: 3162651
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M; Piccoli PL; Gandini G; Giuffrida A; Bressan F; De Gironcoli M; Aprili G
    Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of Salmonella species to four "classical" antibiotics and seven new beta-lactamic antibiotics (author's transl)].
    Roy C; Pellicer MT; Segura C; Foz A
    Med Clin (Barc); 1980 Nov; 75(8):327-30. PubMed ID: 6904743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotetan: a second-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.
    Gribble MJ
    CMAJ; 1994 Sep; 151(5):537-42. PubMed ID: 8069799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate production of cephamycin c and clavulanic acid by Streptomyces clavuligerus.
    Thakur R; Roy MK; Dutta NN; Bezbaruah RL
    Indian J Exp Biol; 1999 Oct; 37(10):1031-3. PubMed ID: 10783761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue levels of cefotetan in odonto-stomatological diseases].
    Gismondo MR; Rapisarda E; Lo Bue AM
    G Ital Chemioter; 1985; 32(2):375-7. PubMed ID: 3869117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.